Van Keymeulen A
Adv Exp Med Biol. 2025; 1464():167-184.
PMID: 39821026
DOI: 10.1007/978-3-031-70875-6_10.
Ettlin J, Bauer A, Opitz L, Malbon A, Markkanen E
J Mammary Gland Biol Neoplasia. 2023; 28(1):14.
PMID: 37391533
PMC: 10313573.
DOI: 10.1007/s10911-023-09542-0.
Chen B, Jin W
Front Neurosci. 2023; 17:1200061.
PMID: 37351420
PMC: 10282194.
DOI: 10.3389/fnins.2023.1200061.
Guimaraes L, Webber L, Gaio E, Junior D, Goncalves P, Wick M
Am J Cancer Res. 2023; 13(1):143-160.
PMID: 36777521
PMC: 9906074.
Wang L, Yu L, Shi J, Li F, Zhang C, Xu H
Sci Rep. 2022; 12(1):10641.
PMID: 35739271
PMC: 9226112.
DOI: 10.1038/s41598-022-13835-5.
Wnt Signaling in the Breast: From Development to Disease.
Abreu de Oliveira W, El Laithy Y, Bruna A, Annibali D, Lluis F
Front Cell Dev Biol. 2022; 10:884467.
PMID: 35663403
PMC: 9157790.
DOI: 10.3389/fcell.2022.884467.
In Vitro Anti-cancer Effect of Crataegus oxyacantha Berry Extract on Hormone Receptor Positive and Triple Negative Breast Cancers via Regulation of Canonical Wnt Signaling Pathway.
Kombiyil S, Sivasithamparam N
Appl Biochem Biotechnol. 2022; 195(4):2687-2708.
PMID: 35262883
DOI: 10.1007/s12010-021-03724-4.
R-Spondins 2 and 3 Are Overexpressed in a Subset of Human Colon and Breast Cancers.
Conboy C, Velez-Reyes G, Rathe S, Abrahante J, Temiz N, Burns M
DNA Cell Biol. 2020; 40(1):70-79.
PMID: 33320737
PMC: 7821429.
DOI: 10.1089/dna.2020.5585.
Aberrant WNT/CTNNB1 Signaling as a Therapeutic Target in Human Breast Cancer: Weighing the Evidence.
van Schie E, van Amerongen R
Front Cell Dev Biol. 2020; 8:25.
PMID: 32083079
PMC: 7005411.
DOI: 10.3389/fcell.2020.00025.
The oncogenic potential of small nuclear ribonucleoprotein polypeptide G: a comprehensive and perspective view.
Mabonga L, Kappo A
Am J Transl Res. 2019; 11(11):6702-6716.
PMID: 31814883
PMC: 6895504.
R-spondin 2 Drives Liver Tumor Development in a Yes-Associated Protein-Dependent Manner.
Conboy C, Velez-Reyes G, Tschida B, Hu H, Kaufmann G, Koes N
Hepatol Commun. 2019; 3(11):1496-1509.
PMID: 31701073
PMC: 6824083.
DOI: 10.1002/hep4.1422.
Mycoplasma hyorhinis infection promotes gastric cancer cell motility via β-catenin signaling.
Liu X, Rong Z, Shou C
Cancer Med. 2019; 8(11):5301-5312.
PMID: 31321908
PMC: 6718539.
DOI: 10.1002/cam4.2357.
sFRP1 exerts effects on gastric cancer cells through GSK3β/Rac1‑mediated restraint of TGFβ/Smad3 signaling.
Peng J, Liang S, Li L
Oncol Rep. 2018; 41(1):224-234.
PMID: 30542739
PMC: 6278527.
DOI: 10.3892/or.2018.6838.
Wnt signaling in human and mouse breast cancer: Focusing on Wnt ligands, receptors and antagonists.
Yin P, Wang W, Zhang Z, Bai Y, Gao J, Zhao C
Cancer Sci. 2018; 109(11):3368-3375.
PMID: 30137666
PMC: 6215866.
DOI: 10.1111/cas.13771.
High-frequency deregulated expression of Wnt signaling pathway members in breast carcinomas.
Khan Z, Arafah M, Shaik J, Mahale A, Alanazi M
Onco Targets Ther. 2018; 11:323-335.
PMID: 29391809
PMC: 5769582.
DOI: 10.2147/OTT.S154395.
Molecular Signaling of Progesterone, Growth Hormone, Wnt, and HER in Mammary Glands of Dogs, Rodents, and Humans: New Treatment Target Identification.
Timmermans-Sprang E, Gracanin A, Mol J
Front Vet Sci. 2017; 4:53.
PMID: 28451590
PMC: 5389977.
DOI: 10.3389/fvets.2017.00053.
MicroRNA-206 is differentially expressed in Brca1-deficient mice and regulates epithelial and stromal cell compartments of the mouse mammary gland.
Wronski A, Sandhu G, Milevskiy M, Brewster B, Bridge J, Shewan A
Oncogenesis. 2016; 5:e218.
PMID: 27043663
PMC: 4848838.
DOI: 10.1038/oncsis.2016.27.
Arsenic trioxide inhibits viability and induces apoptosis through reactivating the Wnt inhibitor secreted frizzled related protein-1 in prostate cancer cells.
Zheng L, Jiang H, Zhang Z, Wang K, Wang Q, Li Q
Onco Targets Ther. 2016; 9:885-94.
PMID: 26966376
PMC: 4770067.
DOI: 10.2147/OTT.S92129.
Genetic Variants in the Wnt Signaling Pathway Are Not Associated with Survival Outcome of Non-Small Cell Lung Cancer in a Korean Population.
Yoo S, Hong M, Choi J, Lee J, Baek S, Lee W
J Korean Med Sci. 2016; 31(3):463-6.
PMID: 26955250
PMC: 4779874.
DOI: 10.3346/jkms.2016.31.3.463.
The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.
Milioli H, Vimieiro R, Riveros C, Tishchenko I, Berretta R, Moscato P
PLoS One. 2015; 10(7):e0129711.
PMID: 26132585
PMC: 4488510.
DOI: 10.1371/journal.pone.0129711.